Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

General Description

Beam Therapeutics

Youtube Subscribe

...

Ticker: BEAM

Sector: Biotechnology

Beam Therapeutics generated $20.12 million in revenue for the quarter. Beam Therapies generated $21.5 billion in revenue in the first quarter..
...
...
Extended Summary

Beam Therapeutics

Russell Investments Group Ltd. increases stake in Beam Therapeutics; analysts provide mixed ratings and projections - best stocks. Beam Therapies generated $20.12 million in revenue for the quarter. Beam Therapeutics Inc. (US) job application for vp, business development at beam therapeutics. (NASDAQ:BEAM) Job Application for VP, Business Development at Beam Theraputics apply for this job. Beam Therapedutics has an analyst consensus of Moderate Buy, with a price target consensus of $49. Beam Therapeuticss stock price per share is $23.50 today (as of Aug 23, 2023) Beam Therapedutics stock market cap is $1.86B. If you had invested in Beam Theraputics stock at $18.75 your return over the last 3 years would have been 25.33%.

Related Results

...
November 30, 2023 0:19 (London Time)

Beam Therapeutics

Beam Therapeutics (BEAM) has 13.826M shares short, which is 21.51% of float and 8.12 times average daily trading volume. The company is laying off a…
Sector: Biotechnology
Ticker: BEAM
Sentiment: 0.7346
MarketCap: 2,426,375,776.0
High: 30.21 Low: 28.42

Open: 30.14 Close: 28.59 Change: -1.55

Read more →
...
September 15, 2023 0:57 (London Time)

Beam Therapeutics

Beam Therapeutics (BEAM) reported earnings of -$1.08 per share, beating the Zacks Consensus Estimate of $-1.38 per share. Beam Therapies trades on t…
Sector: Biotechnology
Ticker: BEAM
Sentiment: 0.836
MarketCap: 1,982,363,510.0
High: 25.46 Low: 24.88

Open: 25.17 Close: 25.14 Change: -0.03

Read more →
...
October 23, 2023 0:39 (London Time)

Beam Therapeutics

Beam Therapeutics, a Cambridge biotech developing medicines that rely on gene editing, said Thursday that it will lay off about 100 employees, 20 pe…
Sector: Biotechnology
Ticker: BEAM
Sentiment: 0.8947
MarketCap: 1,401,039,172.0
High: 18.34 Low: 16.95

Open: 17.76 Close: 17.69 Change: -0.07

Read more →
...
August 24, 2023 18:36 (London Time)

Beam Therapeutics

Beam Therapeutics generated $20.12 million in revenue for the quarter. Russell Investments Group Ltd. increases stake.
Sector: Biotechnology
Ticker: BEAM
Sentiment: 0.7506
MarketCap: 1,861,188,273.0
High: 23.46 Low: 22.7

Open: 23.46 Close: 23.19 Change: -0.27

Read more →
Search
Happening Now
Categories